Press Release Expansion Therapeutics Expands Leadership Team with Two Key Appointments; Names World-Renowned Scientist Lynne E. Maquat, Ph.D., to its Scientific Advisory Board Additions strengthen management team and position company to advance portfolio of medicines targeting RNA-mediated diseases…Expansion TherapeuticsJune 17, 2019
Perspectives on Targeting RNA with Small Molecules to Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine – JACS
Press Release Expansion Therapeutics Names Elliot Ehrich, M.D., Chief Medical Officer Former EVP of R&D and Chief Medical Officer at Alkermes joins Expansion to advance portfolio…Expansion TherapeuticsNovember 13, 2018
Matthew D. Disney, Ph.D., Scientific Founder of ExpansionRx, Named BioFlorida’s Entrepreneur of the Year
Event Matthew Disney, Ph.D., Presents at the 2018 Myotonic Dystrophy Foundation Annual Conference Expansion TherapeuticsOctober 4, 2018
